Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Leigh Wellhauser"'
Autor:
Steven V Molinski, Saumel Ahmadi, Wan Ip, Hong Ouyang, Adriana Villella, John P Miller, Po‐Shun Lee, Kethika Kulleperuma, Kai Du, Michelle Di Paola, Paul DW Eckford, Onofrio Laselva, Ling Jun Huan, Leigh Wellhauser, Ellen Li, Peter N Ray, Régis Pomès, Theo J Moraes, Tanja Gonska, Felix Ratjen, Christine E Bear
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 9, Pp 1224-1243 (2017)
Abstract The combination therapy of lumacaftor and ivacaftor (Orkambi®) is approved for patients bearing the major cystic fibrosis (CF) mutation: ΔF508. It has been predicted that Orkambi® could treat patients with rarer mutations of similar “th
Externí odkaz:
https://doaj.org/article/63e4048262714fd991511c4196c2fb6d
Autor:
Saumel Ahmadi, Zoltan Bozoky, Michelle Di Paola, Sunny Xia, Canhui Li, Amy P. Wong, Leigh Wellhauser, Steven V. Molinski, Wan Ip, Hong Ouyang, Julie Avolio, Julie D. Forman-Kay, Felix Ratjen, Jeremy A. Hirota, Johanna Rommens, Janet Rossant, Tanja Gonska, Theo J. Moraes, Christine E. Bear
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-10 (2017)
Cystic fibrosis: toward personalized therapies A new method for evaluating drug responses in patient-derived respiratory tissue promises to help determine the best treatment for each patient with cystic fibrosis (CF). CF patients are highly susceptib
Externí odkaz:
https://doaj.org/article/7ad6ed4d84964bd982f178ae435366d1
Autor:
John Parkinson, Paul D. W. Eckford, Irina Utkina, Michelle Di Paola, Onofrio Laselva, Tarini N.A. Gunawardena, Christine E. Bear, Leigh Wellhauser, Amy P. Wong, Sunny Xia, Zoe Ngan, Jia Xin Jiang, Felix Ratjen, Zoltán Bozóky, Theo J. Moraes
Publikováno v:
Stem Cell Reports
Summary For those people with cystic fibrosis carrying rare CFTR mutations not responding to currently available therapies, there is an unmet need for relevant tissue models for therapy development. Here, we describe a new testing platform that emplo
Autor:
Leigh Wellhauser, Richard P. Bazinet, Denise D. Belsham, Wenyuan He, Kathyrn E Hopperton, Jim T. C. Chen, Andy Tran
Publikováno v:
Journal of Neurochemistry. 159:574-589
A contributing factor to the development of obesity is the consumption of a diet high in saturated fatty acids, such as palmitate. These fats induce hypothalamic neuroinflammation, which dysregulates neuronal function and induces orexigenic neuropept
Autor:
Jennifer A Chalmers, Prasad S Dalvi, Neruja Loganathan, Emma K McIlwraith, Leigh Wellhauser, Anaies Nazarians-Armavil, Judith A Eversley, Haneesha Mohan, Priska Stahel, Satya Dash, Michael B Wheeler, Denise D Belsham
Publikováno v:
Endocrinology
MicroRNAs (miRNAs) expressed in the hypothalamus are capable of regulating energy balance and peripheral metabolism by inhibiting translation of target messenger RNAs (mRNAs). Hypothalamic insulin resistance is known to precede that in the periphery,
Autor:
Sunny Xia, Theo J. Moraes, Claire Bartlett, Janet Jiang, Leigh Wellhauser, Tanja Gonska, Yu-Sheng Wu, Hong Ouyang, Onofrio Laselva, Alexandria Lew, Wan Ip, Christine E. Bear, Saumel Ahmadi
Publikováno v:
Molecular Pharmacology. 96:515-525
ORKAMBI, a combination of the corrector, lumacaftor, and the potentiator, ivacaftor, partially rescues the defective processing and anion channel activity conferred by the major cystic fibrosis-causing mutation, F508del, in in vitro studies. Clinical
Autor:
Gengming He, Ling Jun Huan, Karen Ho, Leigh Wellhauser, Julie Avolio, Janet Rossant, Sanja Stanojevic, Lianna Kyriakopoulou, Felix Ratjen, Kai Du, Michelle Klingel, Christine E. Bear, Theo J. Moraes, Tanja Gonska, Claire Bartlett, Hong Ouyang, Jia Xin Jiang, Lisa J. Strug, Paul D. W. Eckford, Amy P. Wong, Jacqueline McCormack, Jin Ye Yang, Sergio L. Pereira, Lise Munsie
Publikováno v:
Journal of Cystic Fibrosis. 18:35-43
Background Therapies targeting certain CFTR mutants have been approved, yet variations in clinical response highlight the need for in-vitro and genetic tools that predict patient-specific clinical outcomes. Toward this goal, the CF Canada-Sick Kids P
Autor:
J.P. Miller, Ling Jun Huan, Saumel Ahmadi, Felix Ratjen, Régis Pomès, Paul D. W. Eckford, Hong Ouyang, Leigh Wellhauser, Christine E. Bear, Adriana Villella, Ellen Li, Theo J. Moraes, Kethika Kulleperuma, Peter N. Ray, Michelle Di Paola, Onofrio Laselva, Steven Molinski, Wan Ip, Po-Shun Lee, Tanja Gonska, Kai Du
Publikováno v:
EMBO Molecular Medicine
The combination therapy of lumacaftor and ivacaftor (Orkambi ® ) is approved for patients bearing the major cystic fibrosis (CF) mutation: ΔF508 . It has been predicted that Orkambi ® could treat patients with rarer mutations of similar “theraty
Autor:
Leigh Wellhauser, Julie Avolio, Janet Rossant, Canhui Li, Wan Ip, Michelle Di Paola, Steven Molinski, Theo J. Moraes, Tanja Gonska, Julie D. Forman-Kay, Jeremy A. Hirota, Christine E. Bear, Johanna M. Rommens, Sunny Xia, Zoltán Bozóky, Amy P. Wong, Saumel Ahmadi, Felix Ratjen, Hong Ouyang
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-10 (2017)
NPJ Genomic Medicine
NPJ Genomic Medicine
Pulmonary disease is the major cause of morbidity and mortality in patients with cystic fibrosis, a disease caused by mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene. Heterogeneity in CFTR genotype–phenotype relatio
Autor:
Jennifer A. Chalmers, M B Wheeler, Leigh Wellhauser, Denise D. Belsham, Serge Luquet, Prasad S. Dalvi, D Q Tran, D-Yd Han, Julien Castel, Ying Liu, V Luo
Publikováno v:
International Journal of Obesity
International Journal of Obesity, Nature Publishing Group, 2017, 41 (1), pp.149-158. ⟨10.1038/ijo.2016.183⟩
International Journal of Obesity, Nature Publishing Group, 2017, 41 (1), pp.149-158. ⟨10.1038/ijo.2016.183⟩
International audience; BACKGROUND: Consumption of dietary fat is one of the key factors leading to obesity. High-fat diet (HFD)-induced obesity is characterized by induction of inflammation in the hypothalamus; however, the temporal regulation of pr